437 related articles for article (PubMed ID: 34493193)
41. Mesenchymal Stromal Cells Modulate Macrophages in Clinically Relevant Lung Injury Models by Extracellular Vesicle Mitochondrial Transfer.
Morrison TJ; Jackson MV; Cunningham EK; Kissenpfennig A; McAuley DF; O'Kane CM; Krasnodembskaya AD
Am J Respir Crit Care Med; 2017 Nov; 196(10):1275-1286. PubMed ID: 28598224
[TBL] [Abstract][Full Text] [Related]
42. Recent progress in mesenchymal stem cell-based therapy for acute lung injury.
Liang J; Dai W; Xue S; Wu F; Cui E; Pan R
Cell Tissue Bank; 2024 Jun; 25(2):677-684. PubMed ID: 38466563
[TBL] [Abstract][Full Text] [Related]
43. Extracellular Vesicles Derived from Mesenchymal Stem Cells: A Potential Biodrug for Acute Respiratory Distress Syndrome Treatment.
Sun H; Zhang T; Gao J
BioDrugs; 2022 Nov; 36(6):701-715. PubMed ID: 36087245
[TBL] [Abstract][Full Text] [Related]
44. Visualized Analyses of Investigations Upon Mesenchymal Stem/stromal Cell-based Cytotherapy and Underlying Mechanisms for COVID-19 Associated ARDS.
Aitong W; Leisheng Z; Hao Y
Curr Stem Cell Res Ther; 2022; 17(1):2-12. PubMed ID: 34254927
[TBL] [Abstract][Full Text] [Related]
45. Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome.
Harrell CR; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; Volarevic V
Cells; 2019 May; 8(5):. PubMed ID: 31100966
[TBL] [Abstract][Full Text] [Related]
46. Advances of mesenchymal stem cells and their derived extracellular vesicles as a promising therapy for acute respiratory distress syndrome: from bench to clinic.
Zhuang X; Jiang Y; Yang X; Fu L; Luo L; Dong Z; Zhao J; Hei F
Front Immunol; 2023; 14():1244930. PubMed ID: 37711624
[TBL] [Abstract][Full Text] [Related]
47. Differential effects of extracellular vesicles from aging and young mesenchymal stem cells in acute lung injury.
Huang R; Qin C; Wang J; Hu Y; Zheng G; Qiu G; Ge M; Tao H; Shu Q; Xu J
Aging (Albany NY); 2019 Sep; 11(18):7996-8014. PubMed ID: 31575829
[TBL] [Abstract][Full Text] [Related]
48. Mesenchymal Stem Cells in the Treatment of COVID-19.
Guo BC; Wu KH; Chen CY; Lin WY; Chang YJ; Lee TA; Lin MJ; Wu HP
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834246
[TBL] [Abstract][Full Text] [Related]
49. A 'one stone, two birds' approach with mesenchymal stem cells for acute respiratory distress syndrome and Type II diabetes mellitus.
Sababathy M; Ramanathan G; Abd Rahaman NY; Ramasamy R; Biau FJ; Qi Hao DL; Hamid NS
Regen Med; 2023 Dec; 18(12):913-934. PubMed ID: 38111999
[TBL] [Abstract][Full Text] [Related]
50. Fresh and Cryopreserved Human Umbilical-Cord-Derived Mesenchymal Stromal Cells Attenuate Injury and Enhance Resolution and Repair following Ventilation-Induced Lung Injury.
Horie S; Gonzalez H; Brady J; Devaney J; Scully M; O'Toole D; Laffey JG
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884645
[TBL] [Abstract][Full Text] [Related]
51. Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS.
Xu Z; Huang Y; Zhou J; Deng X; He W; Liu X; Li Y; Zhong N; Sang L
Front Immunol; 2021; 12():738697. PubMed ID: 34659231
[TBL] [Abstract][Full Text] [Related]
52. The Promise of Mesenchymal Stem Cells Therapy for Acute Respiratory Distress Syndrome Caused by COVID-19.
Gu J; Zhao Q; Han Z; Han Z
Curr Stem Cell Res Ther; 2021; 16(3):277-285. PubMed ID: 32729428
[TBL] [Abstract][Full Text] [Related]
53. Mesenchymal stromal cell extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDS.
Dutra Silva J; Su Y; Calfee CS; Delucchi KL; Weiss D; McAuley DF; O'Kane C; Krasnodembskaya AD
Eur Respir J; 2021 Jul; 58(1):. PubMed ID: 33334945
[TBL] [Abstract][Full Text] [Related]
54. Therapeutic use of mesenchymal stem cell-derived extracellular vesicles in acute lung injury.
Lee JH; Park J; Lee JW
Transfusion; 2019 Feb; 59(S1):876-883. PubMed ID: 30383895
[TBL] [Abstract][Full Text] [Related]
55. Mesenchymal Stem Cell Therapy for Severe COVID-19 ARDS.
Häberle H; Magunia H; Lang P; Gloeckner H; Körner A; Koeppen M; Backchoul T; Malek N; Handgretinger R; Rosenberger P; Mirakaj V
J Intensive Care Med; 2021 Jun; 36(6):681-688. PubMed ID: 33663244
[TBL] [Abstract][Full Text] [Related]
56. Secretome of Mesenchymal Stem Cells from Consecutive Hypoxic Cultures Promotes Resolution of Lung Inflammation by Reprogramming Anti-Inflammatory Macrophages.
Xu Z; Lin L; Fan Y; Huselstein C; De Isla N; He X; Chen Y; Li Y
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457151
[TBL] [Abstract][Full Text] [Related]
57. Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications.
Chen L; Qu J; Kalyani FS; Zhang Q; Fan L; Fang Y; Li Y; Xiang C
Cell Mol Life Sci; 2022 Feb; 79(3):142. PubMed ID: 35187617
[TBL] [Abstract][Full Text] [Related]
58. Overview of Stem Cell Therapy for Acute Respiratory Distress Syndrome with Focus on COVID 19.
Kaye RJ
Pain Physician; 2020 Aug; 23(4S):S421-S432. PubMed ID: 32942797
[TBL] [Abstract][Full Text] [Related]
59. Mesenchymal stromal cells alleviate acute respiratory distress syndrome through the cholinergic anti-inflammatory pathway.
Zhang X; Wei X; Deng Y; Yuan X; Shi J; Huang W; Huang J; Chen X; Zheng S; Chen J; Chen K; Xu R; Wang H; Li W; Li S; Yi H; Xiang AP
Signal Transduct Target Ther; 2022 Sep; 7(1):307. PubMed ID: 36064538
[TBL] [Abstract][Full Text] [Related]
60. Immunomodulation and Regenerative Capacity of MSCs for Long-COVID.
Loke XY; Imran SAM; Tye GJ; Wan Kamarul Zaman WS; Nordin F
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
